Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

INNOGEN-B (02591) core product included in the "National Medical Insurance Drug List"

DL HOLDINGS GP (01709) intends to subscribe for 19,047,600 shares of YTME.

GENSCRIPT BIO(01548): Legend announces report published at the 2025 ASH Annual Meeting.
INNOGEN-B (02591) core product included in the "National Medical Insurance Drug List"

DL HOLDINGS GP (01709) intends to subscribe for 19,047,600 shares of YTME.

GENSCRIPT BIO(01548): Legend announces report published at the 2025 ASH Annual Meeting.






